Literature DB >> 3708185

Effect of a deep inspiration on expiratory flow in normals and patients with chronic obstructive pulmonary disease.

R D Fairshter.   

Abstract

Normal control subjects and individuals with chronic obstructive pulmonary disease (COPD) were studied by measuring routine lung function tests as well as maximal (MEFV) and partial expiratory flow-volume (PEFV) curves and lung elastic recoil (Pst,L) before and after a total lung capacity (TLC) volume history. In the normal subjects: before bronchodilators airflow increased significantly, whereas Pst,L and upstream segment resistance (Rus) decreased significantly following inspiration to TLC; after administration of inhaled bronchodilators, flow rates were higher on the PEFV than on MEFV curves; nevertheless, because Pst,L decreased substantially following a deep breath, post-bronchodilator Rus was still somewhat reduced by deep inspiration. In the subjects with COPD flow rates on PEFV curves were as high or exceeded flow rates on MEFV curves in 76/100 studies; the ratio of flow rates (PEFV)/flow rates (MEFV) increased as pulmonary function worsened; as in normal subjects, Pst,L diminished in COPD subjects following deep inspiration; although flow rates increased on both PEFV and MEFV curves after bronchodilators, the increments in flow were considerably larger on PEFV maneuvers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708185

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  3 in total

1.  Deep breaths and airway obstruction in asthma.

Authors:  R H Ingram
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 2.  Physiological assessment of inflammation in the peripheral lung of asthmatic patients.

Authors:  R H Ingram
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Association between reduced bronchodilatory effect of deep inspiration and loss of alveolar attachments.

Authors:  Nicola Scichilone; Andreina Bruno; Roberto Marchese; Antonio Maurizio Vignola; Alkis Togias; Vincenzo Bellia
Journal:  Respir Res       Date:  2005-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.